CN105949074A - Synthesis method of O-methyl-D-serine - Google Patents

Synthesis method of O-methyl-D-serine Download PDF

Info

Publication number
CN105949074A
CN105949074A CN201610395009.6A CN201610395009A CN105949074A CN 105949074 A CN105949074 A CN 105949074A CN 201610395009 A CN201610395009 A CN 201610395009A CN 105949074 A CN105949074 A CN 105949074A
Authority
CN
China
Prior art keywords
methyl
serine
reaction
synthetic method
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610395009.6A
Other languages
Chinese (zh)
Other versions
CN105949074B (en
Inventor
李钢
吴法浩
高仰哲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Redwood Biotechnology Co Ltd
Original Assignee
Nanjing Redwood Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Redwood Biotechnology Co Ltd filed Critical Nanjing Redwood Biotechnology Co Ltd
Priority to CN201610395009.6A priority Critical patent/CN105949074B/en
Publication of CN105949074A publication Critical patent/CN105949074A/en
Application granted granted Critical
Publication of CN105949074B publication Critical patent/CN105949074B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/12Formation of amino and carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/34Preparation of optical isomers by separation of optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

The invention discloses a synthesis method of O-methyl-D-serine. The synthesis method includes the following steps that 1, acrylic acid methyl ester is added into a reaction bottle, after the temperature is raised, bromine is dropwise added, after an addition reaction is conducted, decompression and distillation are conducted to remove excessive bromine, methyl alcohol is added to residues, after the temperature is lowered, sodium methylate is added, after an alcoholysis reaction, decompression and distillation are conducted to remove methyl alcohol, ammonium hydroxide is added, after an ammonium hydroxide, concentrated crystallization is conducted, and O-methyl-DL-serine is obtained; 2, acetic acid is added into the reaction bottle, the O-methyl-DL-serine, D-tartaric acid and salicylaldehyde are added in sequence, after the temperature is raised for a reaction, cooling and crystallization are conducted, separation is conducted, and O-methyl-D-serine double salt is obtained; 3, the O-methyl-D-serine double salt is dissolved in a methyl alcohol aqueous solution, ammonium hydroxide is added to regulate PH to be 7-8, crystallization and separation are conducted, and the O-methyl-D-serine is obtained. The synthesis method is mild in reaction temperature, safe to operate, low in cost and high in chirality purity, and raw materials are easy to obtain.

Description

A kind of synthetic method of O-methyl D-serine
Technical field
The invention belongs to chemosynthesis technical field, be specifically related to the synthetic method of a kind of O-methyl D-serine.
Background technology
O-methyl D-serine is alpha-non-natural amino acid, does not has existence form in nature, is the master of synthesis scheme for lacosamide Want intermediate, be widely used in the industry such as medicine.Scheme for lacosamide is treatment epilepsy and the medicine of neuropathic pain.It is a kind of Novel nmda receptor Glycine site combines antagonist, belongs to new class functional amino, is to have brand-new double mechanism to make Anticonvulsant drug.Its alternative promotion sodium channel slowly inactivates and regulates reaction mediating proteins 22 (CRMP22) of subsiding, And CRMP22 may slow down and even stops epilepsy and alleviate the neuropathic pain of diabetes.The mechanism of action of this product is different In other antuepileptics listed, use the patient of the uncontrollable symptom of existing medicine can use this product.Diabetic neuropathic Pain annoyings diabetics greatly, and scheme for lacosamide is used for treating diabetic neuropathic pain well effect. Being colourless to white crystal or crystalline powder under room temperature, micro-smelly, taste is micro-sweet, soluble in water, is insoluble in ethanol, insoluble in ether And n-butyl alcohol.
The key intermediate of synthesis scheme for lacosamide is exactly O-methyl D-serine.
The route of report synthesis scheme for lacosamide has as follows
1) DL-serine methyl ester hydrochloride route, uses S-2-chloro mandelic acid costly, and route is the most long, unfavorable In industrialization.
2) Merschaert Alain O-methyl DL-serine is raw material, splits or enzymatic conversion, although route is short, But being because splitting is all 50% fractionation, so yield is the highest, adds post processing resin treatment and be unfavorable for industrialization.
3) also have been reported that and use acrylic acid route, but the most unresolved back segment chiral inversion yield problem.
4) present industrialization process, is substantially and synthesizes BOC-O-methyl D-serine with BOC-D-serine, then Go with following route synthesis scheme for lacosamide.
But the greatest problem of this technique is exactly that BOC-D-serine is at synthesis BOC-O-methyl D-serine now Time can racemization, obtain only chiral purity 95%.Because needs when that chirality causing synthesizing scheme for lacosamide below not Just can be obtained the scheme for lacosamide of synthesis by purification repeatedly, such scheme for lacosamide comprehensive yield is the highest, high expensive.So it is honest and clean It is the most critically important that valency obtains high chiral key intermediate O-methyl D-serine.
Summary of the invention
For above-mentioned problems of the prior art, the present invention provides a kind of integrated cost cheap, and reaction temperature compares Gentle, it is easy to industrialization, safety, raw material is easy to get, low cost, and chiral purity more than 99.9%.
For solving the problem that above-mentioned prior art exists, the technical scheme that the present invention takes is: a kind of O-methyl D-silk ammonia The synthetic method of acid, it is characterised in that comprise the steps:
1) adding acrylic acid methyl ester. in reaction bulb, drip bromine after intensification, after additive reaction, excess is removed in decompression distillation Bromine, residue add methanol, after cooling add Feldalat NM, after alcoholysis reaction, decompression distillation remove methanol, add ammonia, After ammonolysis reaction, condensing crystallizing obtains O-methyl DL-serine;
2) in reaction bulb add acetic acid, be sequentially added into O-methyl DL-serine, D-tartaric acid and salicylide, heat up into After row reaction, decrease temperature crystalline, separate to obtain O-methyl D-serine double salt;
3) O-methyl D-serine double salt is dissolved in the aqueous solution of methanol, adds ammonia regulation PH to 7-8, crystallization, separate Obtain O-methyl D-serine.
Synthetic route is:
Wherein, use D-tartaric acid as resolution reagent, acetic acid as solvent, make under the catalysis of salicylide O-methyl- DL-serine generation asymmetric transformation react, with traditional method for splitting first than, the chiral purity obtaining product is higher, can reach To more than 99.9%.
Preferably, step 2) in step 2) in D-tartaric acid, the mol ratio of salicylide and O-methyl DL-serine be 1- 1.1:0.028-0.03:1.Produce impurity under these process conditions few, and asymmetric transformation reaction is completely.
Preferably, step 2) reaction temperature 60-70 DEG C, the response time is 8-12h.
Preferably, step 3) in methanol aqueous solution the volumetric concentration of methanol be 65-80%.
Preferably, step 1) in the mol ratio of acrylic acid methyl ester. and bromine be 1:1.25-1.4.
Preferably, step 1) in Feldalat NM addition be 0.8-1.1 mole of acrylic acid methyl ester. times.
Preferably, step 1) in ammonia addition be 3-5 times of acrylic acid methyl ester. weight.
Preferably, step 1) in the reaction temperature of additive reaction be 45-60 degree, the response time is 1h.
Preferably, step 1) in the reaction temperature of additive reaction be-20--10 DEG C of degree, the response time is 4-7h.
Preferably, step 1) in the reaction temperature of additive reaction be 20-25 DEG C of degree, the response time is 2-5h.
The synthetic method of O-methyl D-serine of the present invention, relative to prior art, has the advantage that
1. yield is high, it is possible to obtain the product of chiral purity more than 99.9%.
The most with low cost: the raw material used by the method for the invention is all basic material that is cheap, that be readily available.
3. safety: reaction temperature is gentleer, easily realizes industrialized great production;
Detailed description of the invention
In order to deepen the understanding of the present invention, below in conjunction with embodiment, the invention will be further described, this embodiment It is only used for explaining the present invention, is not intended that limiting the scope of the present invention.
Embodiment 1
1) in reaction bulb add acrylic acid methyl ester. 86g, be warmed up to 50 DEG C dropping bromine 200g, insulation reaction 1 hour, 60 DEG C Concentrating under reduced pressure removes the bromine of excess, and residue adds methanol 500g, cools to-15 DEG C, adds Feldalat NM 50g, and insulation reaction 5 is little Time, reaction terminates concentrating under reduced pressure and removes methanol, adds the ammonia of 300g, and 20-25 DEG C of insulation reaction 3 hours, condensing crystallizing obtains O-methyl DL-serine 101g.
2) reaction bulb adds the acetic acid of 600g, sequentially adds 101g O-methyl DL-serine, D-tartaric acid 126g, and salicylide 3g, be warmed up to 65 DEG C of insulation reaction 10 hours, cool to 20 DEG C crystallize 2 hours, be filtrated to get O-methyl- D-Ser double salt 210g.
3) reaction bulb adds the methanol aqueous solution 550g of 70% (v/v), adds O-methyl D-serine double salt 210g, Regulate PH to 7-8 with ammonia, crystallize 2 hours, be filtrated to get O-methyl D-serine 83g, after testing, content: be more than 98.5%, chiral purity: more than 99.9%.
Embodiment 2
1) in reaction bulb add acrylic acid methyl ester. 215g, be warmed up to 55 DEG C dropping bromine 500g, insulation reaction 1 hour, 60 DEG C concentrating under reduced pressure removes the bromine of excess, and residue adds methanol 1260g, cools to-17 DEG C, adds Feldalat NM 127g, and insulation is anti- Answering 5.5 hours, reaction terminates concentrating under reduced pressure and removes methanol, adds the ammonia of 750g, 20-25 DEG C of insulation reaction 3 hours, concentrates knot Crystalline substance obtains O-methyl DL-serine 260g.
2) reaction bulb adds the acetic acid of 1500g, sequentially adds 260gO-methyl DL-serine, D-tartaric acid 315g, and salicylide 7.5g, be warmed up to 63 DEG C of insulation reaction 11 hours, cools to 20 DEG C and crystallizes 2 hours, is filtrated to get O-first Base-D-Ser double salt 527g.
3) reaction bulb adds the methanol aqueous solution 1400g of 70% (v/v), adds O-methyl D-serine double salt 527g, Regulate PH to 7-8 with ammonia, crystallize 2 hours, be filtrated to get O-methyl D-serine 210g, after testing, content: be more than 98.5%, chiral purity: more than 99.9%.
The foregoing is only presently preferred embodiments of the present invention, not in order to limit the present invention, all essences in the present invention Within god and principle, any modification, equivalent substitution and improvement etc. made, should be included within the scope of the present invention.

Claims (10)

1. the synthetic method of O-methyl D-serine, it is characterised in that comprise the steps:
1) adding acrylic acid methyl ester. in reaction bulb, drip bromine after intensification, after additive reaction, the bromine of excess is removed in decompression distillation Element, residue adds methanol, adds Feldalat NM after cooling, and after alcoholysis reaction, methanol is removed in decompression distillation, adds ammonia, ammonolysis After reaction, condensing crystallizing obtains O-methyl DL-serine;
2) acetic acid added in reaction bulb, is sequentially added into O-methyl DL-serine, D-tartaric acid and salicylide, and intensification is carried out After reaction, decrease temperature crystalline, separate to obtain O-methyl D-serine double salt;
3) O-methyl D-serine double salt is dissolved in methanol aqueous solution, adds ammonia regulation PH to 7-8, crystallization, isolated O- Methyl D-serine.
The synthetic method of a kind of O-methyl D-serine the most according to claim 1, it is characterised in that step 2) in D- Tartaric acid, salicylide are 1-1.1:0.028-0.03:1 with the mol ratio of O-methyl DL-serine.
The synthetic method of a kind of O-methyl D-serine the most according to claim 1 and 2, it is characterised in that step 2) Reaction temperature 60-70 DEG C, the response time is 8-12h.
The synthetic method of a kind of O-methyl D-serine the most according to claim 1, it is characterised in that first in step 3) In alcohol-water solution, the volumetric concentration of methanol is 65-80%.
The synthetic method of a kind of O-methyl D-serine the most according to claim 1, it is characterised in that in step 1) third The mol ratio of e pioic acid methyl ester and bromine is 1:1.25-1.4.
The synthetic method of a kind of O-methyl D-serine the most according to claim 1, it is characterised in that first in step 1) Sodium alkoxide addition is 0.8-1.1 mole times of acrylic acid methyl ester..
The synthetic method of a kind of O-methyl D-serine the most according to claim 1, it is characterised in that ammonia in step 1) Water addition is 3-5 times of acrylic acid methyl ester. weight.
The synthetic method of a kind of O-methyl D-serine the most according to claim 1, it is characterised in that add in step 1) The reaction temperature becoming reaction is 45-60 degree, and the response time is 1h.
The synthetic method of a kind of O-methyl D-serine the most according to claim 1, it is characterised in that add in step 1) The reaction temperature becoming reaction is-20--10 DEG C of degree, and the response time is 4-7h.
The synthetic method of a kind of O-methyl D-serine the most according to claim 1, it is characterised in that add in step 1) The reaction temperature becoming reaction is 20-25 DEG C of degree, and the response time is 2-5h.
CN201610395009.6A 2016-06-03 2016-06-03 A kind of synthetic method of O methyl D serines Active CN105949074B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610395009.6A CN105949074B (en) 2016-06-03 2016-06-03 A kind of synthetic method of O methyl D serines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610395009.6A CN105949074B (en) 2016-06-03 2016-06-03 A kind of synthetic method of O methyl D serines

Publications (2)

Publication Number Publication Date
CN105949074A true CN105949074A (en) 2016-09-21
CN105949074B CN105949074B (en) 2018-03-02

Family

ID=56908843

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610395009.6A Active CN105949074B (en) 2016-06-03 2016-06-03 A kind of synthetic method of O methyl D serines

Country Status (1)

Country Link
CN (1) CN105949074B (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182718A (en) * 1977-10-25 1980-01-08 Monsanto Company 1,3-Dioxolane and 1,3-dioxane polycarboxylates, and precursors thereof
EP2487152A1 (en) * 2010-11-17 2012-08-15 UCB Pharma GmbH Process for the preparation of Lacosamide including resolution of O-methyl-DL-serine
WO2014068333A2 (en) * 2012-11-01 2014-05-08 Cambrex Karlskoga Ab New process
WO2014072992A1 (en) * 2012-11-12 2014-05-15 Aarti Industries Limited A process for preparing triazole compounds
CN105237419A (en) * 2015-09-18 2016-01-13 南京红杉生物科技有限公司 Method for synthesizing L-norvaline

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182718A (en) * 1977-10-25 1980-01-08 Monsanto Company 1,3-Dioxolane and 1,3-dioxane polycarboxylates, and precursors thereof
EP2487152A1 (en) * 2010-11-17 2012-08-15 UCB Pharma GmbH Process for the preparation of Lacosamide including resolution of O-methyl-DL-serine
WO2014068333A2 (en) * 2012-11-01 2014-05-08 Cambrex Karlskoga Ab New process
WO2014072992A1 (en) * 2012-11-12 2014-05-15 Aarti Industries Limited A process for preparing triazole compounds
CN105237419A (en) * 2015-09-18 2016-01-13 南京红杉生物科技有限公司 Method for synthesizing L-norvaline

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAROLD D. WEST ETAL: "A Publication of Reliable Methods for the Preparation of Organic Compounds", 《ORGANIC SYNTHESES》 *

Also Published As

Publication number Publication date
CN105949074B (en) 2018-03-02

Similar Documents

Publication Publication Date Title
CN106810426B (en) Method for synthesizing cannabidiol
CN104356016B (en) A method of with recycling preparation 3- isobutylglutaric acid monoamides
EP1674446B1 (en) A method of preparing memantine hydrochloride
CN108892627B (en) Process for synthesizing taurine by one-pot method
CN104356012A (en) Preparation method of sarpogrelate hydrochloride photodegradation impurities
CN104557576A (en) Method for preparing high-purity pregabalin
CN105949074A (en) Synthesis method of O-methyl-D-serine
CN103254047B (en) Method for preparing L-menthol intermediate d-citronellal
CN104829422A (en) Method for splitting D,L-menthol
CN102381995B (en) Preparation method of metoprolol
CN104177271B (en) A kind of preparation method of ALC
CN105461516A (en) A synthetic process of L-menthol
CN106316873A (en) Novel method for preparing L-carnitine
CN103709092B (en) The preparation method of Mitiglinide Calcium
CN103554127A (en) Preparation method of beta-artemether
CN103272646B (en) Catalyst for preparing L-menthol intermediate d-citronellal and preparation method thereof
CN103467350A (en) Method for preparing (S)-azetidine-2-carboxylic acid
CN102659561A (en) Method for preparing S-benzylsuccinic acid
CN110441447B (en) Deuterated sulfamethoxazole-d4Method of synthesis of
CN106834374B (en) Enzyme catalysis method for preparing L-aspartic acid (2,3, 3-D)3) Method (2)
CN104193630B (en) A kind of chemical resolution preparation method of S-configuration lyrica
CN107129437A (en) The preparation method of 4- [(2- chloroethyl -2- ethoxys) amino -]-L-phenylalanine hydrochloride and application
CN100546973C (en) The preparation method of 3-(N-methyl-N-penta amino) propionic salt hydrochlorate
CN107235963B (en) A method of efficiently preparing Irbesartan impurity A
CN102557922A (en) Synthesizing method of cis-3-hydroxyl-3-methylcyclobutanecarboxylic acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: Synthesis method of O-methyl-D-serine

Effective date of registration: 20181018

Granted publication date: 20180302

Pledgee: Bank of Jiangsu Limited by Share Ltd Nanjing Longjiang branch

Pledgor: NANJING REDWOOD BIOTECHNOLOGY CO., LTD.

Registration number: 2018320000235

PE01 Entry into force of the registration of the contract for pledge of patent right